semaglutide and eating disorders Ozempic is hailed as a miracle drug. But how does it affect people with disorders? | Eating GLP-1 and Eating Disorders: Risks
Description
Outcomes in cardiometabolic risk GLP1R expression has been detected at low levels in human atria and ventricles, both in cardiomyocytes and endothelial cells, though its precise localization remains unclear due to limitations in antibody specificity and differences at species level [93]
Those changes dont go away with time
Key takeaways Regain is common after stopping
GLP-1 receptor agonists emerge as promising therapies for MASLD, addressing metabolic dysfunction and offering potential improvements in liver health and fibrosis management
